← The Wire
NNNNNasdaq
Anbio Biotechnology
In Vitro & In Vivo Diagnostic Substances · E9 · CIK 1982708
Anbio Biotechnology offers innovative products and services, facing risks in development, market acceptance, and regulatory compliance
$684M
Market cap
$13.55
Last close
-6.7%
1D
-17.7%
5D
35K
Volume
Price · last 39 sessions-54.8%
May 4L $13.55 · H $34.44Jun 29
10
Total filings
May 19, 2026
Last filing
12/31
Fiscal year end
6-KFORM 6-KMay 19, 20266-KFORM 6-KApr 27, 202620-FFORM 20-FApr 7, 20266-KFORM 6-KFeb 17, 20266-KFORM 6-KJan 26, 20266-KREPORT OF FOREIGN PRIVATE ISSUERDec 30, 20256-KREPORT OF FOREIGN PRIVATE ISSUERNov 13, 202520-FANNUAL REPORTApr 28, 20256-KREPORT OF FOREIGN PRIVATE ISSUERFeb 21, 2025424B4PROSPECTUSFeb 19, 2025
Similar companies
Comparable business profile · signals at a glance